MX2009010713A - Formulacion herbaria para el tratamiento de fracturas de huesos y defectos oseos. - Google Patents

Formulacion herbaria para el tratamiento de fracturas de huesos y defectos oseos.

Info

Publication number
MX2009010713A
MX2009010713A MX2009010713A MX2009010713A MX2009010713A MX 2009010713 A MX2009010713 A MX 2009010713A MX 2009010713 A MX2009010713 A MX 2009010713A MX 2009010713 A MX2009010713 A MX 2009010713A MX 2009010713 A MX2009010713 A MX 2009010713A
Authority
MX
Mexico
Prior art keywords
osseum
herbal formulation
treatment
defects
bone fractures
Prior art date
Application number
MX2009010713A
Other languages
English (en)
Inventor
Alfredo Avila
Original Assignee
Alfredo Avila
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfredo Avila filed Critical Alfredo Avila
Publication of MX2009010713A publication Critical patent/MX2009010713A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una formulación herbaria que incluye extracto de Symphytum Officinalis y extracto de Phytolacca Decandra puede combinarse para tratar las fracturas de huesos y los defectos óseos. Específicamente, la formulación herbaria proporciona la regeneración del tejido óseo para tratar defectos de hueso tal como osteogenesis imperfecta, pseudo-artrosis infectada o no, retraso de unión de hueso de fracturas, osteoporosis, tumores óseos, quiste óseo aneurismático y mieloma múltiple.
MX2009010713A 2007-04-02 2008-04-01 Formulacion herbaria para el tratamiento de fracturas de huesos y defectos oseos. MX2009010713A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90745107P 2007-04-02 2007-04-02
PCT/US2008/004220 WO2008123970A1 (en) 2007-04-02 2008-04-01 Herbal formulation for the treatment of bone fractures and osseous defects

Publications (1)

Publication Number Publication Date
MX2009010713A true MX2009010713A (es) 2009-12-15

Family

ID=39794790

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009010713A MX2009010713A (es) 2007-04-02 2008-04-01 Formulacion herbaria para el tratamiento de fracturas de huesos y defectos oseos.

Country Status (4)

Country Link
US (2) US7871648B2 (es)
JP (1) JP5374491B2 (es)
MX (1) MX2009010713A (es)
WO (1) WO2008123970A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012065944A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag N-aryl pyrazole(thio)carboxamides
CN111084780A (zh) * 2020-01-09 2020-05-01 昆明医科大学 老鹳草素在制备治疗骨质疏松合并骨折的药物中的用途
RU2758135C1 (ru) * 2021-01-25 2021-10-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ лечения больных с замедленной консолидацией переломов костей нижней трети голени

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0789862A (ja) * 1990-05-29 1995-04-04 Toyobo Co Ltd 抗炎症性、免疫抑制性および鎮痛性組成物、およびこれらの組成物を用いた自己免疫疾患の治療方法
EP0619116A3 (en) * 1993-04-05 1994-11-23 Hoechst Japan Use of synthetic retinoids for osteopathy.
GB2311009B (en) * 1996-03-06 2000-01-26 Mohd Taufiq Khan Pharmaceutical compositions containing tagetes plants
JPH10194917A (ja) * 1997-01-14 1998-07-28 Noevir Co Ltd 抗菌性低刺激化粧料
US20070020724A1 (en) 1998-06-16 2007-01-25 Ruben Steven M 94 human secreted proteins
US6479545B1 (en) 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
RO120121B1 (ro) * 2000-12-18 2005-09-30 Elena Ionaşcu Soluţie injectabilă, cu efect antiinflamator, procedeu de obţinere şi metodă de tratament a bolilor autoimune
JP2002193733A (ja) * 2000-12-25 2002-07-10 Kanebo Ltd 化粧料
US20030203843A1 (en) 2001-04-20 2003-10-30 Pena Carol E. A. Proteins and nucleic acids encoding same
AU2003228336B2 (en) 2002-03-19 2009-07-30 Curagen Corporation Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1514540B1 (en) * 2002-05-01 2014-08-27 Hayashibara Co., Ltd. Calcium-containing tissue strengthening agents and use thereof
JP2005126327A (ja) * 2003-10-21 2005-05-19 Pola Chem Ind Inc 化粧崩れ防止化粧料
WO2006032091A2 (en) * 2004-09-21 2006-03-30 Lavender Hill Projects Pty Ltd Herbal composition

Also Published As

Publication number Publication date
US8337910B2 (en) 2012-12-25
US20080241277A1 (en) 2008-10-02
JP5374491B2 (ja) 2013-12-25
US7871648B2 (en) 2011-01-18
JP2010523563A (ja) 2010-07-15
US20110076345A1 (en) 2011-03-31
WO2008123970A1 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
WO2006135915A3 (en) Methods and compositions for treating degenerative bone disorders
MX2010006363A (es) Sistemas, aparatos, metodos y procedimientos para el tratamiento no invasivo de tejido usando energia de microondas.
EA201300116A1 (ru) Антагонисты активина-actriia и применение для стимуляции роста кости у больных раком
MX2009006466A (es) Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina.
WO2007022427A3 (en) Methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway
WO2007092622A3 (en) Compositions and methods for treating bone
UA107667C2 (uk) Лікарські сполуки, що модулюють активність піруваткінази-м2, композиції на їх основі та застосування при лікуванні раку
MX350046B (es) Tratamientos para trastornos gastrointestinales.
WO2009079451A3 (en) Compositions and methods of promoting wound healing
NI201200090A (es) Composiciones para tratar náusea y vómito centralmente mediados
IN2015DN01568A (es)
EP2136814A4 (en) MEDICAL KITS AND FORMULATIONS FOR PREVENTING, TREATING OR REDUCING SECONDARY FRACTURES FROM A PREVIOUS FRACTURE
EP3488877A4 (en) IMPLANT AND KIT FOR TREATING BONE LESION SITES AND METHOD FOR TREATING LESION SITES
WO2010132697A3 (en) Methods and compositions for treatment
WO2009105723A3 (en) Novel methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway
HK1124918A1 (zh) +- 宫頸非典型增生和宫頸癌中的 +、 +腺苷三磷酸酶表達
WO2009108857A3 (en) Combination therapy for prostate cancer
WO2009052090A3 (en) Silicate containing compositions and methods of treatment
MX2009010713A (es) Formulacion herbaria para el tratamiento de fracturas de huesos y defectos oseos.
BR112015023080A2 (pt) composto, composição farmacêutica, e, método para tratamento de doenças
WO2007106909A3 (en) Method of using pomegranate extracts for increasing prostate specific antigen doubling time
EP3996614C0 (de) Frakturfixationsplatte zur applikation am proximalen humerus
WO2009078022A3 (en) Synergistic combinations of growth factors with herbal compositions for the enhancement of tissue repair
UA33098U (ru) Способ лечения переломов скулового комплекса с дефектами слизистой оболочки верхнечелюстной пазухи
WO2010111443A3 (en) Omentum as a source of stromal/stem cells and medical treatments using omentum stromal/stem cells

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration